ArticleThe Journal of international medical research2020

Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.

Zhen-Bin Diao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.